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ABSTRACT: Plant medicine becomes more popular thought the world in these days probably of 
its latest toxicity. Ayurveda that leads in plant medicine preserves the natural form of herbs 
maximum, in various pharmaceutical preparations. Isolation of active principles has not proved 
much fruitful. However, the need of hour is cultivation of more medicinal plants along with 
popularization of their use traditional simpler forms. 
 
INTRODUCTION. 
 
Plant medicine appears to be most safe 
because of its proximity to the nature. Now 
there is occurring  a growing trend of 
acceptance of plant medicine world-wide 
because synthetic or chemical drugs are 
proving toxic or idiosyncratic on both the 
short or long term use. Ayurveda leads in 
use of plant drugs.  
 
Developing or changing socio-economic-
cultural structure of humanity is causing a 
great hazard to plant drug community. Drug 
are decreasing ability, deterioration in 
quality, lack of identification, adulteration, 
decreasing populatory, half heart 
commercialization of Ayurvedic Pharmacy 
system etc. 
 
Plant Drug Research. 
 
Surprisingly, we have not so far decided our 
approach to plant drug research. There is a 
lack of definite understanding in this area. 
One  has to decide whether we have to 
promote the isolation and use of active 
principles of plant drugs or to encourage the 
use of whole plant such as or both. Probably 
research scientists of 20
th century have used 
their talent and research capabilities on the 
isolation of active principles but have 
yielded hardly few drugs of plant origin like 
reserpine. How over, this failure has not 
affected the use of plant drugs in Ayurvedic 
physicians are using the plants with the 
same enthusiasm and probably with the 
same success. 
 
Recently many clinical trials have confirmed 
the efficiency of plant drugs in their crude 
form on scientific background. Few  such 
examples include powder of many herbs like 
powder of Satavari8 (Asparagusracemosus) 
root and Amalaki15  (Emblica officinale) 
fruit in peptic ulcer disease, paste of whole 
plant of Kalmegha4  (Andrographis 
paniculata) infective hepatitis, stem bark 
powder of Kutaja (Holarrhena 
antidysenterica) in intestinal amoebiasis, 
seed powder of jambu (Eugenia Jambolana) 
and decoction of root of Arani (clerodendron 
phlomidis) in non-insulin dependent 
diabetes mellitus, stem bark of Arjuna 
(Terminalia arjuna) in heart diseases, 
Asvagandha (Withania somnifera)  powder Pages 154-158 
In anxiety neurosis  etc.  Therefore, the 
approach to plant drug research should 
promote the use of whole plant as such. 
 
The Perspectives 
 
There should be a change in trend of 
research done by Ayurvedic scholars. They 
should render their research potentialities to 
clinical trials. Both the patterns of clinical 
research e.g. Ayurvedic diagnosis  and 
Ayurvedic treatment as recommended by 
udupa committee, 1958  can be adopted 
according to suitability with the research 
model. More importantly, the results of 
clinical  trials  should be communicated to 
practitioners, scientists and also the general 
mass through suitable media. It warrants the 
publications of clinical trials in scientific as 
well as popular journals in different 
languages having an appropriate level of 
understanding Ayurvedic research workers 
should not unduly involved in chemical, 
experimental or pharmacological studies of 
medicinal plants. These studies should be 
done with the aim to develop modern new 
drugs of plant origin by scientists not by 
Ayurvedic Physicians need not  be lead in 
developing new drugs from plant sources. 
They should do more and more clinical trials 
and should popularize their findings to 
scientists, practitioners as well as population 
at large through mass media. 
 
Chemists and scientists may be needed more 
importantly to help in identifying the toxic 
constituents, if any,  in plant drugs. They 
may be further helpful in finding a way to 
eliminate the toxic element. One leading 
branch of Ayurvedic medicine is rasa sastra 
which primarily deals with elimination of 
toxic constituents of various plants and 
minerals, commonly used in Ayurveda. This 
process is termed as ‘Sodhana karma’. Rasa-
sastra for example have methods to 
eliminate the toxicity of plants such as 
Kupilu (Strychnous nuxvomica), Dhatura 
(datura stromonium)., Vatsanabha 
(Aconitum ferox) etc. therefore a 
collaborative study of Rasa-Sastra scholars 
and chemists may be fruitful since they can 
find a way to identify as well as eliminate 
the toxic and unwanted constituents so that 
the whole plant may be used as such with 
greater safety and without isolation of active 
principles.  It will also be necessary to 
identify the parts of medicinal value of each 
of these plants, and the seasonal variation 
and age of the plant in the content of their 
priate chemical  and pharmacological 
studies. For example  alkaloid content is 
found maximum in kutaja (Holarhena 
antidysentrica) at the age of 8 nt0 12 years 
and just after rains from July to September. 
 
Besides plants may be more used in favor of 
advance of organic chemistry but gain on 
the  discretion  of chemists. Chemistry 
departments abroad for instance in 
University of Brono, Czechoslovakia have 
big plant garden with a perspective to do 
research in plant chemistry dot necessarily 
to promote pharmaceutical research. 
 
Adherence to conventional 
Pharmaceutical Procedures 
 
Natural use of plants should be popularized. 
This can be met through Ayurveda by 
encouraging the use of plant drugs in five 
basic dosage forms collectively termed 
Panca Vidha kasaya Kalpana1  namely 
Swaras (juice) Kalka (Paste or Powder), Srta 
(decoction), Sita( cold perfusion) and 
Phanta(hot perfusion). This will be in 
pursuance of primary health care as the 
methods are practicable, technology is 
universally accessible to individuals and 
families in the community through full 
participation and, moreover the community 
and country can afford the cost maintaining 
it at every stage of their development in the Pages 154-158 
spirit of self reliance and self-determination. 
Industrialization of traditional pharmacy 
system has increased the cost of medical 
care several times. Even the cost of 
Ayurvedic drugs produced by private sector 
industries is mainly times higher than those 
produced by public sector pharmacies. The 
aforementioned panca vidha Kasaya 
Kalpanas will be home remedy, cheap and 
probably more effective. It  will reduce the 
element of industrilalization. This will be 
more importantly in pursuance of Alma-Ata 
Declaration – “Health for all by 2000 A.D., 
 
Cultivation of Plant Drugs 
 
It is not amazing that plants are the major 
source of raw materials for preparation of 
drugs used in Traditional systems of 
medicine throughout the world including the 
Ayurveda. In earlier days such plants used to 
be easily available locally for medicinal use 
and such no need was felt to cultivate them. 
And, hence, no element of 
commercialization and marketing was 
needed. In recent years with the changing 
ecology, there has been a rapid depletion of 
such plants on the face of a growing demand 
due to coming up industrialization in the 
field of Ayurvedic drugs to meet the 
increased drug requirement of the growing 
population. Now, therefore, it is felt at all 
levels that the medicinal plants should be 
cultivated at large scale. This will help not 
only making the raw drugs easily available 
but will also provide an opportunity of 
improving the quality of raw materials. 
 
At present there is a need of exposure of 
plants of medicinal value at public level. 
This can be achieved with the involvement 
of primary health centre. Each primary 
health centre should have a plant garden 
particularly for demonstration purposes. 
Simultaneously, use of such plants as 
medicine should be explained to the persons 
of that area along with the method of 
preparation of adopting Panca vidha kasaya 
Kalpanas. Thus, plant medicine will be a 
within the reach of poorer sections of 
society. 
 
Approach to Cultivation of Medicinal 
Plants. 
 
As regards the cultivation of medicinal 
plants, it should be done in three phases. In I 
phase ‘priority program’ has to be evaluated 
e.g. to find out the plants which have strong 
demand in the market and | or have strong 
demonstrable clinical effect of early onset 
that can make an impact on its producer or 
user.  Alternative list of 50 essential  plant 
drugs for primary health care has been 
reported earlier. Further a committee can be 
formed with the view to know the plant 
drugs of strong demand. Simultaneously, 
requirement assessment of individual drug 
should be evaluated which will be again 
helpful in ‘priority program’.  
 
In II phase a wide  ecological survey of 
medicinal plants should be launched to study 
the habitat of these plants in order to select 
proper cultivating sites and seasons and 
certain other details to each plant. Package 
of practice related to each plant drug should 
be collected  –  (i) from literature, (ii) by 
interweaving  the local persons where the 
drug naturally occur in abundance or (iii) it 
may have to be developed by trial and error 
methods. In beginning, few villages should 
be selected e.g. ‘clusters’ for the cultivation 
of plant drugs. Procurement of seeds is a 
further problem which can be handled with 
the help of local persons. Later on, newer 
techniques for plant breeding, plant culture 
and genetic engineering should be applied to 
develop medicinal plants havening the 
greater yield of active components. Such a 
program could easily be launched in Pages 154-158 
collaboration with plant scientists and 
agricultural sciences. 
 
Promotion and consumption of plant should 
be dealt in III phase just parallel to II phase. 
The phenomenon of co-operative cultivation 
of medicinal plants. This cultivation should 
be on the pattern of each crops to create an 
inscentive in the cultivator, and National 
Drug Authority of India (NDA) should take 
lead in this area. A suitable market should 
be created for the consumption of plant 
drugs so that the cultivator can get the cost 
of his labour and necessary incentive and 
encouragement. It warrants the creation of a 
strong price control system’. Easily 
available freely or without prop4er cost to 
consumers or drug manufactures. 
Unavailability  of plants of natural 
abundance will be the final outcome, if, 
price control system is not adopted strictly. 
Meanwhile, contract system like that of 
leaves used in Bidi manufacturing should be 
followed to initiative the interest of 
cultivation of medicinal plants in farmers. 
Consumption can be further increased if 
contract is made with drug manufactures 
either directs through cultivators and 
consumers with the aid of radio, television, 
video, journals or periodicals. 
 
Thus with the changing values and 
development in the use of plant drugs, there 
is a strong  need of rethinking on the polices 
and perspectives in the area of research and 
exploitation of plants of medicinal use. The 
experiences of last few decades have also 
emphasized the need of review of 
approaches. Plants being the natural source 
of medicaments established for their values 
since antiquity need not to be put to undue 
examination in the name of research. It is 
more important to popularize their existing 
use and to work for their easy and persistent 
availability. However, the scientists of sister 
disciplines may use plants as a source of 
developing newer chemicals and drugs, if 
they find it feasible and useful. In view of 
the facts discussed above it is always 
advisable to draw out Ayurveda from 
extreme traditionalism  and over claims. 
And, at the same time, it should be protected 
from too much science and scientific 
jugglery. Enough scope should be provided 
to the art of medicine to emerge. 
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